Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2025-12-24 @ 11:47 PM
NCT ID:
NCT05327751
Eligibility Criteria:
Inclusion criteria:
* Age: 18-65 years old.
* Gender: Male and female.
* Newly diagnosed colorectal cancer patients who are scheduled to receive capecitabine-based chemotherapy.
* Eastern Cooperative Oncology Group (ECOG) performance status \< 2
* Patients with adequate renal function (Sr. creatinine \< 1.2 mg/dl or eGFR ≥ 90 ml/min).
* Patients with adequate hepatic function (Sr. bilirubin \< 1.2 mg/dl).
Exclusion criteria:
* Pregnant and lactating females.
* Patients with cardiovascular disease (congestive heart failure, cardiac arrhythmia, or coronary artery disease, …. etc.).
* History of H-Pylori infection.
* Patients with a known hypersensitivity to any of the used drugs.
* Patients with any contraindication to any of the used drugs.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT05327751
Study Brief:
Protocol Section:
NCT05327751